Yohei Shirakami - Search Results

Year	Number of Results
2007	2
2008	6
2009	7
2010	4
2011	4
2012	7
2013	6
2014	9
2015	7
2016	7
2017	5
2018	4
2019	3
2020	3
2021	6
2022	2

1

Possible Mechanisms of Green Tea and Its Constituents against Cancer.

Shirakami Y, Shimizu M. Shirakami Y, et al. Molecules. 2018 Sep 7;23(9):2284. doi: 10.3390/molecules23092284. Molecules. 2018. PMID: 30205425 Free PMC article. Review.

2

Catechins and Its Role in Chronic Diseases.

Shirakami Y, Sakai H, Kochi T, Seishima M, Shimizu M. Shirakami Y, et al. Adv Exp Med Biol. 2016;929:67-90. doi: 10.1007/978-3-319-41342-6_4. Adv Exp Med Biol. 2016. PMID: 27771921 Review.

3

Retinoid roles in blocking hepatocellular carcinoma.

Shirakami Y, Sakai H, Shimizu M. Shirakami Y, et al. Hepatobiliary Surg Nutr. 2015 Aug;4(4):222-8. doi: 10.3978/j.issn.2304-3881.2015.05.01. Hepatobiliary Surg Nutr. 2015. PMID: 26311412 Free PMC article. Review.

4

Prevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation.

Shirakami Y, Ohnishi M, Sakai H, Tanaka T, Shimizu M. Shirakami Y, et al. Int J Mol Sci. 2017 Apr 26;18(5):908. doi: 10.3390/ijms18050908. Int J Mol Sci. 2017. PMID: 28445390 Free PMC article. Review.

5

Hepatic metabolism of retinoids and disease associations.

Shirakami Y, Lee SA, Clugston RD, Blaner WS. Shirakami Y, et al. Biochim Biophys Acta. 2012 Jan;1821(1):124-36. doi: 10.1016/j.bbalip.2011.06.023. Epub 2011 Jul 1. Biochim Biophys Acta. 2012. PMID: 21763780 Free PMC article. Review.

6

Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis.

Miyazaki T, Shirakami Y, Mizutani T, Maruta A, Ideta T, Kubota M, Sakai H, Ibuka T, Genovese S, Fiorito S, Taddeo VA, Epifano F, Tanaka T, Shimizu M. Miyazaki T, et al. Among authors: shirakami y. Sci Rep. 2021 Jan 12;11(1):492. doi: 10.1038/s41598-020-79916-5. Sci Rep. 2021. PMID: 33436792 Free PMC article.

7

Chemopreventive potential of green tea catechins in hepatocellular carcinoma.

Shimizu M, Shirakami Y, Sakai H, Kubota M, Kochi T, Ideta T, Miyazaki T, Moriwaki H. Shimizu M, et al. Among authors: shirakami y. Int J Mol Sci. 2015 Mar 17;16(3):6124-39. doi: 10.3390/ijms16036124. Int J Mol Sci. 2015. PMID: 25789501 Free PMC article. Review.

8

Chemoprevention of colorectal cancer by targeting obesity-related metabolic abnormalities.

Shirakami Y, Shimizu M, Kubota M, Araki H, Tanaka T, Moriwaki H, Seishima M. Shirakami Y, et al. World J Gastroenterol. 2014 Jul 21;20(27):8939-46. doi: 10.3748/wjg.v20.i27.8939. World J Gastroenterol. 2014. PMID: 25083066 Free PMC article. Review.

9

Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents.

Sakai H, Shirakami Y, Shimizu M. Sakai H, et al. Among authors: shirakami y. World J Gastroenterol. 2016 Jan 7;22(1):394-406. doi: 10.3748/wjg.v22.i1.394. World J Gastroenterol. 2016. PMID: 26755885 Free PMC article. Review.

10

Clinical Characteristics of Nursing- and Healthcare-Associated Tuberculosis.

Suzuki T, Kato T, Ohnishi R, Yasuda S, Sano K, Shirakami Y, Shimizu M, Murakami N. Suzuki T, et al. Among authors: shirakami y. Diseases. 2018 Nov 11;6(4):101. doi: 10.3390/diseases6040101. Diseases. 2018. PMID: 30423855 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results